Role of Microenvironment in Resistance to Therapy in AML
- 29 April 2015
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Hematologic Malignancy Reports
- Vol. 10 (2), 96-103
- https://doi.org/10.1007/s11899-015-0253-6
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanismJournal of Cell Science, 2014
- Niche-based screening identifies small-molecule inhibitors of leukemia stem cellsNature Chemical Biology, 2013
- CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic nichesExperimental Biology and Medicine, 2013
- The vascular niche: home for normal and malignant hematopoietic stem cellsLeukemia, 2011
- Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100Blood, 2009
- Targeting of CD44 eradicates human acute myeloid leukemic stem cellsNature Medicine, 2006
- Signals from the Sympathetic Nervous System Regulate Hematopoietic Stem Cell Egress from Bone MarrowCell, 2006
- Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1Nature Medicine, 2004
- Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow NicheCell, 2004
- Stromal abnormalities in neoplastic bone marrow diseasesAnnals of Hematology, 1996